NCT06736990: A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
- State
- Under way
- Phase
- Phase 2
- People
- 150 planned
- Started
- 20 Jun 2025
- Primary completion
- Nov 2026
- Arms
- CAL101
- Results
- None posted
- 17 Dec 2024: Trial registered
- 20 Jun 2025: Trial started